Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Bensinger

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Blood|February 1, 1988
Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trialsR Storb, H J Deeg, L Fisher, et al.
The New England Journal of Medicine|March 20, 1986
Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemiaR Storb, H J Deeg, J Whitehead, et al.
Blood|July 1, 1986
Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host diseaseR Storb, H J Deeg, V Farewell, et al.
Blood|May 1, 1989
Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trialR Storb, H J Deeg, M Pepe, et al.
Bone Marrow Transplantation|March 1, 1993
Consequences of cryopreserving first remission autologous marrow for use after relapse in patients with acute myeloid leukemiaK Schiffman, R Clift, F R Appelbaum, et al.
Seminars in Hematology|July 1, 1991
Marrow transplantation for severe aplastic anemia and thalassemia majorR Storb, C Anasetti, F Appelbaum, et al.
Blood|May 1, 1994
Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemiaR Storb, W Leisenring, H J Deeg, et al.
Bone Marrow Transplantation|January 1, 1992
Changing trends in marrow transplantation for aplastic anemiaR Storb, G Longton, C Anasetti, et al.
British Journal of Haematology|August 1, 1989
Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trialR Storb, H J Deeg, M Pepe, et al.
Experimental Hematology|January 1, 1987
Preparation of red-blood-cell-depleted marrow for ABO-incompatible marrow transplantation by density-gradient separation using the IBM 2991 blood cell processorN R Jin, R Hill, G Segal, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Blood|February 1, 1988
Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trialsR Storb, H J Deeg, L Fisher, et al.
The New England Journal of Medicine|March 20, 1986
Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemiaR Storb, H J Deeg, J Whitehead, et al.
Blood|July 1, 1986
Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host diseaseR Storb, H J Deeg, V Farewell, et al.
Blood|May 1, 1989
Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trialR Storb, H J Deeg, M Pepe, et al.
Bone Marrow Transplantation|March 1, 1993
Consequences of cryopreserving first remission autologous marrow for use after relapse in patients with acute myeloid leukemiaK Schiffman, R Clift, F R Appelbaum, et al.
Seminars in Hematology|July 1, 1991
Marrow transplantation for severe aplastic anemia and thalassemia majorR Storb, C Anasetti, F Appelbaum, et al.
Blood|May 1, 1994
Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemiaR Storb, W Leisenring, H J Deeg, et al.
Bone Marrow Transplantation|January 1, 1992
Changing trends in marrow transplantation for aplastic anemiaR Storb, G Longton, C Anasetti, et al.
British Journal of Haematology|August 1, 1989
Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trialR Storb, H J Deeg, M Pepe, et al.
Experimental Hematology|January 1, 1987
Preparation of red-blood-cell-depleted marrow for ABO-incompatible marrow transplantation by density-gradient separation using the IBM 2991 blood cell processorN R Jin, R Hill, G Segal, et al.
Pageof 6